The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
about
PREDICT modeling and in-silico screening for G-protein coupled receptors.The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: summary of clinical trials.Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.Pregabalin and gabapentin inhibit substance P-induced NF-kappaB activation in neuroblastoma and glioma cells.The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
P2860
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The pharmacology of GR203040, ...... kinin NK1 receptor antagonist.
@en
The pharmacology of GR203040, ...... kinin NK1 receptor antagonist.
@nl
type
label
The pharmacology of GR203040, ...... kinin NK1 receptor antagonist.
@en
The pharmacology of GR203040, ...... kinin NK1 receptor antagonist.
@nl
prefLabel
The pharmacology of GR203040, ...... kinin NK1 receptor antagonist.
@en
The pharmacology of GR203040, ...... kinin NK1 receptor antagonist.
@nl
P2093
P2860
P1476
The pharmacology of GR203040, ...... kinin NK1 receptor antagonist.
@en
P2093
A B Hawcock
D T Beattie
F H Marshall
H E Connor
I J Beresford
P2860
P304
P356
10.1111/J.1476-5381.1995.TB15117.X
P407
P577
1995-12-01T00:00:00Z